Evidence map›Paper›PMID 28404664›Full record

ReviewJournal of the American Society of Nephrology : JASN2017

New Insights into Podocyte Biology in Glomerular Health and Disease.

Suheir Assady, Nicola Wanner, Karl L Skorecki, Tobias B Huber

Abstract readReview
In one paragraph

Review in Journal of the American Society of Nephrology : JASN, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Podocyte FFAR4 deficiency aggravated glomerular diseases and aging.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Podocyte cell-specificPhysiological genomics · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Suheir AssadyDepartment of Nephrology and Hypertension, Rambam Health Care Campus, Haifa, Israel.
Nicola WannerDepartment of Medicine IV, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Karl L SkoreckiDepartment of Nephrology and Hypertension, Rambam Health Care Campus, Haifa, Israel; skorecki@tx.technion.ac.il t.huber@uke.de.
Tobias B HuberDepartment of Medicine IV, Faculty of Medicine, University of Freiburg, Freiburg, Germany; skorecki@tx.technion.ac.il t.huber@uke.de.

Funding

European Research Council 616891
6 · The paper itself

Abstract

Podocyte and glomerular research is center stage for the development of improved preventive and therapeutic strategies for chronic progressive kidney diseases. Held April 3-6, 2016, the 11th International Podocyte Conference took place in Haifa and Jerusalem, Israel, where participants from all over the world presented their work on new developments in podocyte research. In this review, we briefly highlight the advances made in characterizing the mechanisms involved in podocyte development, metabolism, acquired injury, and repair, including progress in determining the roles of genetic variants and microRNA in particular, as well as the advances made in diagnostic techniques and therapeutics.

Indexed as

AnimalsBiomedical ResearchHumansKidney DiseasesKidney GlomerulusMicroRNAsPodocytesSignal TransductionStem CellsMicroRNAsglomerular basement membraneglomerular diseasepodocyteslit diaphragm

Identifiers

PMID28404664
PMCPMC5461807

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.